Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Price to Book Ratio 2006–2026
Price to book (P/B) ratio for Cyclacel Pharmaceuticals, Inc. (BGMS): market cap divided by shareholder equity. As of March 31, 2026 it is 0.80.
From: 09/30/2025To: 03/31/2026
Stock Price
Book Value
Price to Book
Cyclacel Pharmaceuticals, Inc. Price to Book Ratio — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) price to book ratio over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGMS's price to book ratio history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s price to book ratio by year and by quarter, including the growth rate.